Cidara Therapeutics Inc.

San Diego, CA Part of Merck Sharp & Dohme LLC

UEI
FKP3JZ9RUNY9
CAGE
7A5L2
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
Corporate family
SAM.gov registration date
Physical address
6310 Nancy Ridge Dr #101, San Diego, CA 92121, USA
Website
merck.com
Founded
1891
Employees
50K-100K
Estimated annual revenue
$10B+
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Cidara Therapeutics Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Development of CD388 as a long-lasting prophylactic anti-viral option for protection against the health impacts caused… Contract · 75A50125C00017 Office of the Assistant Secretary for Preparedness and Response $58,051,983

Quick answers

What is Cidara Therapeutics Inc.'s UEI?

Cidara Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is FKP3JZ9RUNY9.

What is Cidara Therapeutics Inc.'s CAGE code?

Cidara Therapeutics Inc.'s CAGE code is 7A5L2.

What is Cidara Therapeutics Inc.'s primary NAICS code?

Cidara Therapeutics Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Cidara Therapeutics Inc. located?

Cidara Therapeutics Inc.'s physical address in SAM.gov is 6310 Nancy Ridge Dr #101, San Diego, CA 92121, USA.

Is Cidara Therapeutics Inc. registered in SAM.gov?

Yes. Cidara Therapeutics Inc.'s SAM.gov registration is active through July 6, 2027.

Who is Cidara Therapeutics Inc.'s parent company?

Cidara Therapeutics Inc. is part of Merck Sharp & Dohme LLC.

What is Cidara Therapeutics Inc.'s most recent federal award?

Cidara Therapeutics Inc.'s most recent federal contract award is Development of CD388 as a long-lasting prophylactic anti-viral option for protection against the health impacts caused… (75A50125C00017), from Office of the Assistant Secretary for Preparedness and Response, on September 30, 2025.

On GovTribe

See Cidara Therapeutics Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login